Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.

Recruiting now

Conditions studied: Breast Cancer

In brief

This is multicentric, spontaneous, observational, retrospective and prospective study.

Key facts

Study ID

NCT05817227

Run by

National Cancer Institute, Naples

People needed

300

Starts

2022-05-19

Expected to finish

2027-11-19

Last updated by the study team

2025-12-22

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• TNBC breast cancer patients, before any drug treatment
• healthy women aged 25-60

You may not qualify if…

• donors suffering from diabetes, hypertension, active infectious states, HIV infection, Hepatitis B or C, chronic inflammatory diseases, current or previous neoplasms, heart disease or drug treatment.

Where it is running

• Istituto Nazionale Tumori - Fondazione "G.Pascale", IRCCS — Naples, Napoli, Italy (enrolling)
• Istituto Nazionale Tumori Regina Elena — Roma, Roma, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.